How to buy Wegovy at the 0.25mg starting dose in the UK

Your consultation is free, fill in a health questionnaire and a real GPhC-registered Independent Prescriber reviews it the same day, not software.
Identity and current weight are verified before any prescription is issued, because that is what safe clinical practice requires.
Order before 12pm Monday to Friday and, once approved, your treatment is dispatched the same day by tracked DPD in plain, unbranded packaging.
Next-working-day delivery is included in the price, alongside your prescription, aftercare access seven days a week, and no subscription tie-in.

The only legal route to Wegovy's 0.25mg starting dose in the UK is through a prescription, issued by a qualified prescriber after a clinical assessment of your health. Wegovy is a prescription-only medicine — no pharmacy, online or otherwise, can supply it without one. If you've been looking into this and feeling like the process is more complicated than it should be, that's a fair reaction: the landscape of online clinics varies enormously in quality and rigour. This page sets out exactly how a legitimate private prescription route works, what to look for in any provider you consider, and how nume's consultation process is structured — so you can make a straightforward, informed decision.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The four decisions that actually determine whether you get the right prescription safely

Decision one: private route or NHS waiting list?

Wegovy is available on the NHS, but only through specialist weight management services and subject to criteria set by NICE's appraisal of semaglutide (TA875). In practice that means a referral, a multidisciplinary programme, and waiting lists that currently run to months or longer in most areas. Many people who qualify on paper cannot access treatment quickly through that route.

A private prescription sidesteps the wait entirely. The clinical bar does not disappear (a prescriber still assesses every application individually) but the timeline compresses from months to the same working day. If you're not sure whether your BMI and health history would meet the standard private eligibility criteria, the Wegovy overview page sets out the licensed thresholds in plain terms.

Worth being clear: choosing a private route does not mean a lower standard of care. It means a different funding model and a much shorter queue.

Decision two: which online pharmacy is actually registered to dispense?

This is the decision that matters most for safety. The MHRA has issued repeated public warnings about fake weight-loss pens sold via social media and unverified websites, counterfeit pens have contained insulin and caused serious harm. In October 2025 the first illicit UK site manufacturing fake tirzepatide pens was raided; enforcement across 2025 resulted in roughly 20 million doses of illegally traded medicines (around £45m street value) being seized. The risk is real and ongoing.

Every legitimate UK online pharmacy must be registered with the General Pharmaceutical Council. You can check any pharmacy against the GPhC register directly, nume's registration number is 9012878. The check takes about thirty seconds and is the clearest signal you have that a supplier operates within the law. If a seller is offering Wegovy without a clinical assessment, at prices far below the market range, or via a social media DM, those are hard stops. Report suspect sellers at the MHRA's Yellow Card portal.

The full guide to buying Wegovy in the UK covers what else to look for when comparing providers.

Decision three: do you meet the eligibility criteria for a private prescription?

Wegovy is licensed in the UK for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition, for example hypertension, high cholesterol, type 2 diabetes, prediabetes, or obstructive sleep apnoea. For some ethnic backgrounds, UK guidance applies a threshold that is 2.5 kg/m² lower. The NHS semaglutide page gives a reliable, plain-English account of how the medicine works and who it is used for.

BMI alone does not decide the outcome. A prescriber looks at your full picture: medical history, current medicines, any conditions that would make this treatment unsuitable. There are contraindications (pregnancy, breastfeeding, trying to conceive, certain thyroid conditions, a history of pancreatitis) and these are assessed at consultation, not assumed from a number. The nume FAQs page addresses the questions we hear most often from people at this stage.

One practical note: if you have existing private health insurance and wonder whether that changes anything, the guide to Wegovy and private health insurance is worth a read before you commit to any payment route.

Decision four: what does the 0.25mg dose actually start?

The 0.25mg weekly dose is the first step of a titration schedule, not the dose at which most people see significant appetite changes. Its job is to let your system adjust to the medicine before the prescriber steps up the dose, reducing the likelihood of severe nausea or digestive discomfort in the early weeks. Treatment then climbs gradually through 0.5mg, 1mg, 1.7mg and eventually 2.4mg, with each step guided by how you're tolerating the current level. When the time comes to increase your injection, you can buy your Wegovy 0.5mg pen here once your prescriber confirms you're ready to move up, and later move on to the 1mg step-up dose once your prescriber is satisfied with your progress.

At nume, every repeat order is reviewed individually before dispatch. That means a named prescriber looks at your progress each time, not just at your first application. If you have questions between orders, aftercare is available seven days a week. You can also read more about 0.25mg stock availability if that is what prompted your search today.

The consultation is free, there is no subscription, and treatment pricing is shown clearly on the treatment page rather than buried in a checkout flow. Check your eligibility there when you're ready.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions